Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
SAGE
Sage Therapeutics
Last Price:
4.98
Seasonality Move:
10.16%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.36 | Sell |
20-day SMA: | 6.23 | Sell |
50-day SMA: | 6.81 | Sell |
200-day SMA: | 12.15 | Sell |
8-day EMA: | 5.29 | Sell |
20-day EMA: | 5.93 | Sell |
50-day EMA: | 6.83 | Sell |
200-day EMA: | 12.15 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 29.07 | Sell |
Chaikin Money Flow: | 217390 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.36 - 7.64) | Sell |
Bollinger Bands (100): | (6.26 - 10.18) | Sell |
Sage Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 4.91 while SAGE 8-day simple moving average is 5.36, which is a Sell signal.
- The stock price of SAGE is 4.91 while Sage Therapeutics 20-day SMA is 6.23, which makes it a Sell.
- Sage Therapeutics 50-day simple moving average is 6.81 while SAGE share price is 4.91, making it a Sell technically.
- SAGE stock price is 4.91 and Sage Therapeutics 200-day simple moving average is 12.15, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $4.91. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
300.36M
Price in USD:
4.91
Share Volume:
1.58M
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
4.74
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 4.91 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 4.91 while SAGE 8-day exponential moving average is 5.29, which is a Sell signal.
- The stock price of SAGE is 4.91 while Sage Therapeutics 20-day EMA is 5.93, which makes it a Sell.
- Sage Therapeutics 50-day exponential moving average is 6.83 while SAGE share price is 4.91, making it a Sell technically.
- SAGE stock price is 4.91 and Sage Therapeutics 200-day simple moving average is 12.15, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.36 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 29.07, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (5.36 - 7.64), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (6.26 - 10.18), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.